The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pemetrexed Diacid Market Research Report 2025
Synopsis
The global Pemetrexed Diacid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Pemetrexed Diacid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pemetrexed Diacid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pemetrexed Diacid include Eli Lilly and Company, Natco Pharma Ltd, United Biotech India Pvt.Ltd., Actiza Parma, Beacon Pharma, ChemOthersapy, Onkos, Emcure and Cytotoxic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pemetrexed Diacid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pemetrexed Diacid.
Report Scope
The Pemetrexed Diacid market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pemetrexed Diacid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pemetrexed Diacid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Natco Pharma Ltd
United Biotech India Pvt.Ltd.
Actiza Parma
Beacon Pharma
ChemOthersapy
Onkos
Emcure
Cytotoxic
Pemgem
Lianyungang Tengfa Bio-tech Co., Ltd.
Nanjing Pharmaceutical Factory Co., Ltd.
Qilu Pharma
Segment by Type
100mg Injection
200mg Injection
300mg Injection
500mg Injection
Segment by Application
Mesothelioma
Non-Small Cell Lung Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pemetrexed Diacid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pemetrexed Diacid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Pemetrexed Diacid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Pemetrexed Diacid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pemetrexed Diacid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pemetrexed Diacid include Eli Lilly and Company, Natco Pharma Ltd, United Biotech India Pvt.Ltd., Actiza Parma, Beacon Pharma, ChemOthersapy, Onkos, Emcure and Cytotoxic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pemetrexed Diacid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pemetrexed Diacid.
Report Scope
The Pemetrexed Diacid market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pemetrexed Diacid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pemetrexed Diacid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Natco Pharma Ltd
United Biotech India Pvt.Ltd.
Actiza Parma
Beacon Pharma
ChemOthersapy
Onkos
Emcure
Cytotoxic
Pemgem
Lianyungang Tengfa Bio-tech Co., Ltd.
Nanjing Pharmaceutical Factory Co., Ltd.
Qilu Pharma
Segment by Type
100mg Injection
200mg Injection
300mg Injection
500mg Injection
Segment by Application
Mesothelioma
Non-Small Cell Lung Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pemetrexed Diacid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pemetrexed Diacid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pemetrexed Diacid Market Overview
1.1 Product Overview and Scope of Pemetrexed Diacid
1.2 Pemetrexed Diacid Segment by Type
1.2.1 Global Pemetrexed Diacid Market Value Comparison by Type (2024-2030)
1.2.2 100mg Injection
1.2.3 200mg Injection
1.2.4 300mg Injection
1.2.5 500mg Injection
1.3 Pemetrexed Diacid Segment by Application
1.3.1 Global Pemetrexed Diacid Market Value by Application: (2024-2030)
1.3.2 Mesothelioma
1.3.3 Non-Small Cell Lung Cancer
1.3.4 Others
1.4 Global Pemetrexed Diacid Market Size Estimates and Forecasts
1.4.1 Global Pemetrexed Diacid Revenue 2019-2030
1.4.2 Global Pemetrexed Diacid Sales 2019-2030
1.4.3 Global Pemetrexed Diacid Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pemetrexed Diacid Market Competition by Manufacturers
2.1 Global Pemetrexed Diacid Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pemetrexed Diacid Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pemetrexed Diacid Average Price by Manufacturers (2019-2024)
2.4 Global Pemetrexed Diacid Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pemetrexed Diacid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pemetrexed Diacid, Product Type & Application
2.7 Pemetrexed Diacid Market Competitive Situation and Trends
2.7.1 Pemetrexed Diacid Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pemetrexed Diacid Players Market Share by Revenue
2.7.3 Global Pemetrexed Diacid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pemetrexed Diacid Retrospective Market Scenario by Region
3.1 Global Pemetrexed Diacid Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pemetrexed Diacid Global Pemetrexed Diacid Sales by Region: 2019-2030
3.2.1 Global Pemetrexed Diacid Sales by Region: 2019-2024
3.2.2 Global Pemetrexed Diacid Sales by Region: 2025-2030
3.3 Global Pemetrexed Diacid Global Pemetrexed Diacid Revenue by Region: 2019-2030
3.3.1 Global Pemetrexed Diacid Revenue by Region: 2019-2024
3.3.2 Global Pemetrexed Diacid Revenue by Region: 2025-2030
3.4 North America Pemetrexed Diacid Market Facts & Figures by Country
3.4.1 North America Pemetrexed Diacid Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pemetrexed Diacid Sales by Country (2019-2030)
3.4.3 North America Pemetrexed Diacid Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pemetrexed Diacid Market Facts & Figures by Country
3.5.1 Europe Pemetrexed Diacid Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pemetrexed Diacid Sales by Country (2019-2030)
3.5.3 Europe Pemetrexed Diacid Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pemetrexed Diacid Market Facts & Figures by Country
3.6.1 Asia Pacific Pemetrexed Diacid Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pemetrexed Diacid Sales by Country (2019-2030)
3.6.3 Asia Pacific Pemetrexed Diacid Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pemetrexed Diacid Market Facts & Figures by Country
3.7.1 Latin America Pemetrexed Diacid Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pemetrexed Diacid Sales by Country (2019-2030)
3.7.3 Latin America Pemetrexed Diacid Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pemetrexed Diacid Market Facts & Figures by Country
3.8.1 Middle East and Africa Pemetrexed Diacid Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pemetrexed Diacid Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pemetrexed Diacid Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pemetrexed Diacid Sales by Type (2019-2030)
4.1.1 Global Pemetrexed Diacid Sales by Type (2019-2024)
4.1.2 Global Pemetrexed Diacid Sales by Type (2025-2030)
4.1.3 Global Pemetrexed Diacid Sales Market Share by Type (2019-2030)
4.2 Global Pemetrexed Diacid Revenue by Type (2019-2030)
4.2.1 Global Pemetrexed Diacid Revenue by Type (2019-2024)
4.2.2 Global Pemetrexed Diacid Revenue by Type (2025-2030)
4.2.3 Global Pemetrexed Diacid Revenue Market Share by Type (2019-2030)
4.3 Global Pemetrexed Diacid Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pemetrexed Diacid Sales by Application (2019-2030)
5.1.1 Global Pemetrexed Diacid Sales by Application (2019-2024)
5.1.2 Global Pemetrexed Diacid Sales by Application (2025-2030)
5.1.3 Global Pemetrexed Diacid Sales Market Share by Application (2019-2030)
5.2 Global Pemetrexed Diacid Revenue by Application (2019-2030)
5.2.1 Global Pemetrexed Diacid Revenue by Application (2019-2024)
5.2.2 Global Pemetrexed Diacid Revenue by Application (2025-2030)
5.2.3 Global Pemetrexed Diacid Revenue Market Share by Application (2019-2030)
5.3 Global Pemetrexed Diacid Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly and Company
6.1.1 Eli Lilly and Company Corporation Information
6.1.2 Eli Lilly and Company Description and Business Overview
6.1.3 Eli Lilly and Company Pemetrexed Diacid Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly and Company Pemetrexed Diacid Product Portfolio
6.1.5 Eli Lilly and Company Recent Developments/Updates
6.2 Natco Pharma Ltd
6.2.1 Natco Pharma Ltd Corporation Information
6.2.2 Natco Pharma Ltd Description and Business Overview
6.2.3 Natco Pharma Ltd Pemetrexed Diacid Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Natco Pharma Ltd Pemetrexed Diacid Product Portfolio
6.2.5 Natco Pharma Ltd Recent Developments/Updates
6.3 United Biotech India Pvt.Ltd.
6.3.1 United Biotech India Pvt.Ltd. Corporation Information
6.3.2 United Biotech India Pvt.Ltd. Description and Business Overview
6.3.3 United Biotech India Pvt.Ltd. Pemetrexed Diacid Sales, Revenue and Gross Margin (2019-2024)
6.3.4 United Biotech India Pvt.Ltd. Pemetrexed Diacid Product Portfolio
6.3.5 United Biotech India Pvt.Ltd. Recent Developments/Updates
6.4 Actiza Parma
6.4.1 Actiza Parma Corporation Information
6.4.2 Actiza Parma Description and Business Overview
6.4.3 Actiza Parma Pemetrexed Diacid Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Actiza Parma Pemetrexed Diacid Product Portfolio
6.4.5 Actiza Parma Recent Developments/Updates
6.5 Beacon Pharma
6.5.1 Beacon Pharma Corporation Information
6.5.2 Beacon Pharma Description and Business Overview
6.5.3 Beacon Pharma Pemetrexed Diacid Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Beacon Pharma Pemetrexed Diacid Product Portfolio
6.5.5 Beacon Pharma Recent Developments/Updates
6.6 ChemOthersapy
6.6.1 ChemOthersapy Corporation Information
6.6.2 ChemOthersapy Description and Business Overview
6.6.3 ChemOthersapy Pemetrexed Diacid Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ChemOthersapy Pemetrexed Diacid Product Portfolio
6.6.5 ChemOthersapy Recent Developments/Updates
6.7 Onkos
6.6.1 Onkos Corporation Information
6.6.2 Onkos Description and Business Overview
6.6.3 Onkos Pemetrexed Diacid Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Onkos Pemetrexed Diacid Product Portfolio
6.7.5 Onkos Recent Developments/Updates
6.8 Emcure
6.8.1 Emcure Corporation Information
6.8.2 Emcure Description and Business Overview
6.8.3 Emcure Pemetrexed Diacid Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Emcure Pemetrexed Diacid Product Portfolio
6.8.5 Emcure Recent Developments/Updates
6.9 Cytotoxic
6.9.1 Cytotoxic Corporation Information
6.9.2 Cytotoxic Description and Business Overview
6.9.3 Cytotoxic Pemetrexed Diacid Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cytotoxic Pemetrexed Diacid Product Portfolio
6.9.5 Cytotoxic Recent Developments/Updates
6.10 Pemgem
6.10.1 Pemgem Corporation Information
6.10.2 Pemgem Description and Business Overview
6.10.3 Pemgem Pemetrexed Diacid Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pemgem Pemetrexed Diacid Product Portfolio
6.10.5 Pemgem Recent Developments/Updates
6.11 Lianyungang Tengfa Bio-tech Co., Ltd.
6.11.1 Lianyungang Tengfa Bio-tech Co., Ltd. Corporation Information
6.11.2 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Description and Business Overview
6.11.3 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Product Portfolio
6.11.5 Lianyungang Tengfa Bio-tech Co., Ltd. Recent Developments/Updates
6.12 Nanjing Pharmaceutical Factory Co., Ltd.
6.12.1 Nanjing Pharmaceutical Factory Co., Ltd. Corporation Information
6.12.2 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Description and Business Overview
6.12.3 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Product Portfolio
6.12.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments/Updates
6.13 Qilu Pharma
6.13.1 Qilu Pharma Corporation Information
6.13.2 Qilu Pharma Pemetrexed Diacid Description and Business Overview
6.13.3 Qilu Pharma Pemetrexed Diacid Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Qilu Pharma Pemetrexed Diacid Product Portfolio
6.13.5 Qilu Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pemetrexed Diacid Industry Chain Analysis
7.2 Pemetrexed Diacid Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pemetrexed Diacid Production Mode & Process
7.4 Pemetrexed Diacid Sales and Marketing
7.4.1 Pemetrexed Diacid Sales Channels
7.4.2 Pemetrexed Diacid Distributors
7.5 Pemetrexed Diacid Customers
8 Pemetrexed Diacid Market Dynamics
8.1 Pemetrexed Diacid Industry Trends
8.2 Pemetrexed Diacid Market Drivers
8.3 Pemetrexed Diacid Market Challenges
8.4 Pemetrexed Diacid Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pemetrexed Diacid Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pemetrexed Diacid Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pemetrexed Diacid Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pemetrexed Diacid Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Pemetrexed Diacid Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pemetrexed Diacid Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pemetrexed Diacid Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pemetrexed Diacid Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pemetrexed Diacid, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pemetrexed Diacid, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pemetrexed Diacid, Product Type & Application
Table 12. Global Key Manufacturers of Pemetrexed Diacid, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pemetrexed Diacid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pemetrexed Diacid as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pemetrexed Diacid Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pemetrexed Diacid Sales by Region (2019-2024) & (K Dose)
Table 18. Global Pemetrexed Diacid Sales Market Share by Region (2019-2024)
Table 19. Global Pemetrexed Diacid Sales by Region (2025-2030) & (K Dose)
Table 20. Global Pemetrexed Diacid Sales Market Share by Region (2025-2030)
Table 21. Global Pemetrexed Diacid Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pemetrexed Diacid Revenue Market Share by Region (2019-2024)
Table 23. Global Pemetrexed Diacid Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pemetrexed Diacid Revenue Market Share by Region (2025-2030)
Table 25. North America Pemetrexed Diacid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pemetrexed Diacid Sales by Country (2019-2024) & (K Dose)
Table 27. North America Pemetrexed Diacid Sales by Country (2025-2030) & (K Dose)
Table 28. North America Pemetrexed Diacid Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pemetrexed Diacid Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pemetrexed Diacid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pemetrexed Diacid Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Pemetrexed Diacid Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Pemetrexed Diacid Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pemetrexed Diacid Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pemetrexed Diacid Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pemetrexed Diacid Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Pemetrexed Diacid Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Pemetrexed Diacid Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pemetrexed Diacid Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pemetrexed Diacid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pemetrexed Diacid Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Pemetrexed Diacid Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Pemetrexed Diacid Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pemetrexed Diacid Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pemetrexed Diacid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pemetrexed Diacid Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East & Africa Pemetrexed Diacid Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East & Africa Pemetrexed Diacid Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pemetrexed Diacid Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pemetrexed Diacid Sales (K Dose) by Type (2019-2024)
Table 51. Global Pemetrexed Diacid Sales (K Dose) by Type (2025-2030)
Table 52. Global Pemetrexed Diacid Sales Market Share by Type (2019-2024)
Table 53. Global Pemetrexed Diacid Sales Market Share by Type (2025-2030)
Table 54. Global Pemetrexed Diacid Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pemetrexed Diacid Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pemetrexed Diacid Revenue Market Share by Type (2019-2024)
Table 57. Global Pemetrexed Diacid Revenue Market Share by Type (2025-2030)
Table 58. Global Pemetrexed Diacid Price (US$/Dose) by Type (2019-2024)
Table 59. Global Pemetrexed Diacid Price (US$/Dose) by Type (2025-2030)
Table 60. Global Pemetrexed Diacid Sales (K Dose) by Application (2019-2024)
Table 61. Global Pemetrexed Diacid Sales (K Dose) by Application (2025-2030)
Table 62. Global Pemetrexed Diacid Sales Market Share by Application (2019-2024)
Table 63. Global Pemetrexed Diacid Sales Market Share by Application (2025-2030)
Table 64. Global Pemetrexed Diacid Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pemetrexed Diacid Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pemetrexed Diacid Revenue Market Share by Application (2019-2024)
Table 67. Global Pemetrexed Diacid Revenue Market Share by Application (2025-2030)
Table 68. Global Pemetrexed Diacid Price (US$/Dose) by Application (2019-2024)
Table 69. Global Pemetrexed Diacid Price (US$/Dose) by Application (2025-2030)
Table 70. Eli Lilly and Company Corporation Information
Table 71. Eli Lilly and Company Description and Business Overview
Table 72. Eli Lilly and Company Pemetrexed Diacid Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Eli Lilly and Company Pemetrexed Diacid Product
Table 74. Eli Lilly and Company Recent Developments/Updates
Table 75. Natco Pharma Ltd Corporation Information
Table 76. Natco Pharma Ltd Description and Business Overview
Table 77. Natco Pharma Ltd Pemetrexed Diacid Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Natco Pharma Ltd Pemetrexed Diacid Product
Table 79. Natco Pharma Ltd Recent Developments/Updates
Table 80. United Biotech India Pvt.Ltd. Corporation Information
Table 81. United Biotech India Pvt.Ltd. Description and Business Overview
Table 82. United Biotech India Pvt.Ltd. Pemetrexed Diacid Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. United Biotech India Pvt.Ltd. Pemetrexed Diacid Product
Table 84. United Biotech India Pvt.Ltd. Recent Developments/Updates
Table 85. Actiza Parma Corporation Information
Table 86. Actiza Parma Description and Business Overview
Table 87. Actiza Parma Pemetrexed Diacid Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Actiza Parma Pemetrexed Diacid Product
Table 89. Actiza Parma Recent Developments/Updates
Table 90. Beacon Pharma Corporation Information
Table 91. Beacon Pharma Description and Business Overview
Table 92. Beacon Pharma Pemetrexed Diacid Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Beacon Pharma Pemetrexed Diacid Product
Table 94. Beacon Pharma Recent Developments/Updates
Table 95. ChemOthersapy Corporation Information
Table 96. ChemOthersapy Description and Business Overview
Table 97. ChemOthersapy Pemetrexed Diacid Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. ChemOthersapy Pemetrexed Diacid Product
Table 99. ChemOthersapy Recent Developments/Updates
Table 100. Onkos Corporation Information
Table 101. Onkos Description and Business Overview
Table 102. Onkos Pemetrexed Diacid Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Onkos Pemetrexed Diacid Product
Table 104. Onkos Recent Developments/Updates
Table 105. Emcure Corporation Information
Table 106. Emcure Description and Business Overview
Table 107. Emcure Pemetrexed Diacid Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Emcure Pemetrexed Diacid Product
Table 109. Emcure Recent Developments/Updates
Table 110. Cytotoxic Corporation Information
Table 111. Cytotoxic Description and Business Overview
Table 112. Cytotoxic Pemetrexed Diacid Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Cytotoxic Pemetrexed Diacid Product
Table 114. Cytotoxic Recent Developments/Updates
Table 115. Pemgem Corporation Information
Table 116. Pemgem Description and Business Overview
Table 117. Pemgem Pemetrexed Diacid Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. Pemgem Pemetrexed Diacid Product
Table 119. Pemgem Recent Developments/Updates
Table 120. Lianyungang Tengfa Bio-tech Co., Ltd. Corporation Information
Table 121. Lianyungang Tengfa Bio-tech Co., Ltd. Description and Business Overview
Table 122. Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Product
Table 124. Lianyungang Tengfa Bio-tech Co., Ltd. Recent Developments/Updates
Table 125. Nanjing Pharmaceutical Factory Co., Ltd. Corporation Information
Table 126. Nanjing Pharmaceutical Factory Co., Ltd. Description and Business Overview
Table 127. Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 128. Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Product
Table 129. Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments/Updates
Table 130. Qilu Pharma Corporation Information
Table 131. Qilu Pharma Description and Business Overview
Table 132. Qilu Pharma Pemetrexed Diacid Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 133. Qilu Pharma Pemetrexed Diacid Product
Table 134. Qilu Pharma Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Pemetrexed Diacid Distributors List
Table 138. Pemetrexed Diacid Customers List
Table 139. Pemetrexed Diacid Market Trends
Table 140. Pemetrexed Diacid Market Drivers
Table 141. Pemetrexed Diacid Market Challenges
Table 142. Pemetrexed Diacid Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pemetrexed Diacid
Figure 2. Global Pemetrexed Diacid Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pemetrexed Diacid Market Share by Type in 2023 & 2030
Figure 4. 100mg Injection Product Picture
Figure 5. 200mg Injection Product Picture
Figure 6. 300mg Injection Product Picture
Figure 7. 500mg Injection Product Picture
Figure 8. Global Pemetrexed Diacid Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Pemetrexed Diacid Market Share by Application in 2023 & 2030
Figure 10. Mesothelioma
Figure 11. Non-Small Cell Lung Cancer
Figure 12. Others
Figure 13. Global Pemetrexed Diacid Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pemetrexed Diacid Market Size (2019-2030) & (US$ Million)
Figure 15. Global Pemetrexed Diacid Sales (2019-2030) & (K Dose)
Figure 16. Global Pemetrexed Diacid Average Price (US$/Dose) & (2019-2030)
Figure 17. Pemetrexed Diacid Report Years Considered
Figure 18. Pemetrexed Diacid Sales Share by Manufacturers in 2023
Figure 19. Global Pemetrexed Diacid Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Pemetrexed Diacid Players: Market Share by Revenue in 2023
Figure 21. Pemetrexed Diacid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Pemetrexed Diacid Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Pemetrexed Diacid Sales Market Share by Country (2019-2030)
Figure 24. North America Pemetrexed Diacid Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Pemetrexed Diacid Sales Market Share by Country (2019-2030)
Figure 28. Europe Pemetrexed Diacid Revenue Market Share by Country (2019-2030)
Figure 29. Germany Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Pemetrexed Diacid Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Pemetrexed Diacid Revenue Market Share by Region (2019-2030)
Figure 36. China Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Pemetrexed Diacid Sales Market Share by Country (2019-2030)
Figure 47. Latin America Pemetrexed Diacid Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Pemetrexed Diacid Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Pemetrexed Diacid Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Pemetrexed Diacid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Pemetrexed Diacid by Type (2019-2030)
Figure 57. Global Revenue Market Share of Pemetrexed Diacid by Type (2019-2030)
Figure 58. Global Pemetrexed Diacid Price (US$/Dose) by Type (2019-2030)
Figure 59. Global Sales Market Share of Pemetrexed Diacid by Application (2019-2030)
Figure 60. Global Revenue Market Share of Pemetrexed Diacid by Application (2019-2030)
Figure 61. Global Pemetrexed Diacid Price (US$/Dose) by Application (2019-2030)
Figure 62. Pemetrexed Diacid Value Chain
Figure 63. Pemetrexed Diacid Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
